Related content

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

Intratumor heterogeneity of BRAF V600E mutation in lung adenocarcinomas

By                  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1719-1722

Spandidos Publications

Access to resources Recommend Favorite

Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients

By                

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1882-1888

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules

By              

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2633-2638

Spandidos Publications

Access to resources Recommend Favorite

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients

By Ilie M.   Long E.   Hofman V.   Dadone B.   Marquette C. H.   Mouroux J.   Vignaud J. M.   Begueret H.   Merlio J. P.   Capper D.   von Deimling A.   Emile J. F.   Hofman P.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 742-748

Oxford University Press

Access to resources Recommend Favorite